home / stock / bcyc / bcyc news


BCYC News and Press, Bicycle Therapeutics plc

Stock Information

Company Name: Bicycle Therapeutics plc
Stock Symbol: BCYC
Market: NYSE
Website: bicycletherapeutics.com

Menu

BCYC BCYC Quote BCYC Short BCYC News BCYC Articles BCYC Message Board
Get BCYC Alerts

News, Short Squeeze, Breakout and More Instantly...

BCYC - Tracking Baker Brothers Portfolio - Q1 2024 Update

2024-06-11 00:24:03 ET Summary Baker Brothers' 13F portfolio value decreased from $8.79B to $7.97B. The largest five stakes in the portfolio are Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Rhythm Pharma. Baker Brothers has had successful investments in companies that ...

BCYC - Objective long/short (BCYC) Report

2024-06-10 02:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BCYC - Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo

2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...

BCYC - Cytokinetics Decides To Go It Alone

2024-05-24 14:48:52 ET Summary The stock of Cytokinetics, Incorporated plunged 17% in trading on Thursday, largely as the result of a somewhat botched capital raise announcement. The capital raise took a near-term buyout off the table in the short term and left many shareholders f...

BCYC - Bicycle Therapeutics Boosts Balance Sheet To Navigate Data Desert

2024-05-24 12:59:33 ET Summary Bicycle Therapeutics plc has just completed a $555 million private placement equity financing, giving the company approximately $1 billion in cash. The company retains partnerships with major pharmaceutical companies, including Roche, Novartis, Bayer...

BCYC - Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates ® demonstrate differentiation compared to antibody drug conjugates Trial-in-progress poster outlines registrational Phase 2/3 Duravelo-2 trial of BT8009, a Nectin-4 targeted Bicycle Toxin Conjugate,...

BCYC - Bicycle Therapeutics gains as co announces $555M PIPE financing

2024-05-23 09:04:41 ET More on Bicycle Therapeutics Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point Bicycle Therapeutics GAAP EPS of -$0.62 beats by $0.66, revenue of $19.53M beats by $13.5M Cantor sees strong year ahead for oncology M&A...

BCYC - NVIDIA, Dell Technologies, Super Micro Computer among premarket gainers' pack

2024-05-23 08:48:04 ET Greenwave Technology Solutions ( GWAV ) +55% after eliminates all convertible debt . Ascent Solar Technologies ( ASTI ) +49% . Bicycle Therapeutics ( BCYC ) +14% after announces $555 million private placement equity financing ...

BCYC - Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

Financing includes participation from new and existing investors Strengthens balance sheet, with pro forma cash position of approximately $1.0 billion, extending expected financial runway into the second half of 2027 Supports ongoing advancement of pipeline with multiple clinical-...

BCYC - (BCYC) Trading Advice

2024-05-09 10:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Next 10